1 – 10 of 11
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
COVID-19 vaccine effectiveness against severe disease from SARS-CoV-2 Omicron BA.1 and BA.2 subvariants - surveillance results from southern Sweden, December 2021 to March 2022
2022) In Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin 27(18).(
- Contribution to journal › Article
-
Mark
High level of protection against COVID-19 after two doses of BNT162b2 vaccine in the working age population–first results from a cohort study in Southern Sweden
(
- Contribution to journal › Article
- 2021
-
Mark
Effectiveness of the BNT162b2 vaccine in preventing COVID-19 in the working age population – first results from a cohort study in Southern Sweden
2021)(
- Working paper/Preprint › Preprint in preprint archive
-
Mark
Short time to blood culture positivity in Enterococcus faecalis infective endocarditis
(
- Contribution to journal › Article
- 2018
-
Mark
Thrombocytopenia in bacteraemia and association with bacterial species
(
- Contribution to journal › Article
- 2014
-
Mark
Recurrent erysipelas - risk factors and clinical presentation.
(
- Contribution to journal › Article